1) biliary fibrosis
淤胆性肝纤维化
1.
Effects of nitric oxide and endothelin-1 on biliary fibrosis in rats;
一氧化氮和内皮素-1在淤胆性肝纤维化中的作用机制
2) cholestasis-induced liver fibrosis
胆汁淤积性肝纤维化
1.
Effect of chinese medicine Complex prescriptions of different cure laws on PAI-1 mRNA of cholestasis-induced liver fibrosis rat;
不同治则中药复方对胆汁淤积性肝纤维化大鼠PAI-1影响的研究
2.
Objective To study the regulatory effects of the Chinese medicine complex prescriptions Erzhiwan and Shixiaosan on urokinase type plasminogen activator(uPA)/plasminogen activator inhibitor-1(PAI-1)fibrinolytic system cholestasis-induced liver fibrosis rats.
目的研究不同治则中药复方二至丸与失笑散对胆汁淤积性肝纤维化大鼠uPA/PAI-1纤溶途经的调控作用。
3.
Objective To study the effects of the Chinese herbal compound (Erzhiwan, Shixiaosan and combined formula) on cholestasis-induced liver fibrosis rat’s uPA.
目的观察补益肝肾、活血化瘀方二至丸、失笑散及其合方对胆汁淤积性肝纤维化大鼠肝组织尿激酶型纤溶酶原激活剂(uPA)的影响。
3) Fibrosing cholestatic hepatitis
纤维化淤胆性肝炎
5) chronic cholestatic hepatitis
慢性淤胆型肝炎
1.
Therapeutic effect of ligustrazine together with heparin sodium and ursodeoxycholic acid (UDCA) on chronic cholestatic hepatitis.;
川芎嗪注射液联合肝素钠与口服熊去氧胆酸治疗慢性淤胆型肝炎疗效观察
2.
The subject was divided into two parts: The first part:Clinical effect of Yudan decoction on intrahepatic cholestatic jaundice Objective: To observe the therapeutic effect of Yudan decoction in treating jaundice caused by chronic cholestatic hepatitis, and to explore its mechanism preliminarily.
第一部分:愈疸汤治疗肝内胆汁淤积性黄疸的临床观察 目的:观察愈疸汤治疗慢性淤胆型肝炎的退黄效果,并初步探讨其机理。
6) acute viral cholestatic hepatitis
急性淤胆型肝炎
补充资料：肝外阻塞性胆汁性肝硬化
肝外阻塞性胆汁性肝硬化
又称"继发性胆汁性肝硬化。*胆汁性肝硬化的一个类型，继发于肝外胆管阻塞而引起的肝硬化。主要由总胆管结石、手术后胆管狭管、胰头癌、先天性胆管闭锁或缺如等原因所造成。在梗阻上端的胆道由下而上地逐渐扩大迂曲，胆汁淤积，肝内小胆管扩大而破裂，使肝血管受压，胆汁外渗，肝细胞发生缺血、坏死，纤维组织增生，最后形成肝硬化。临床表现为黄疸、肝脾肿大，皮肤粘膜出血倾向，血胆固醇下降等，晚期表现同*肝硬化。解除肝外阻塞原因，本病有治愈的可能性。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条